Wenzel, Jan-Per http://orcid.org/0000-0002-6302-8671
Kellen, Ramona Bei der
Magnussen, Christina
Blankenberg, Stefan
Schrage, Benedikt
Schnabel, Renate
Nikorowitsch, Julius
Funding for this research was provided by:
Fondation Leducq (16 CVD 03)
Deutsche Forschungsgemeinschaft (TH1106/5-1; AA93/2-1)
Innovative Medicines Initiative (116074)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 22 March 2021
Accepted: 7 July 2021
First Online: 16 July 2021
Declarations
:
: SB reports honoraria from Abbott, Siemens, Thermo Fisher, and Roche, outside of the submitted work. CM receives speaker fees from Astra Zeneca, Novartis, and Loewenstein medical unrelated to the submitted work. RBS has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program under the grant agreement No 648131, from the European Union’s Horizon 2020 research and innovation program under the grant agreement No 847770 (AFFECT-EU) and German Center for Cardiovascular Research (DZHK e.V.) (81Z1710103); German Ministry of Research and Education (BMBF 01ZX1408A) and ERACoSysMed3 (031L0239). RBS has received lecture fees and advisory board fees from BMS/Pfizer outside this work.
: The authors do hereby declare that their study complies with the Declaration of Helsinki.